Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 20/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30046582 | 1.00 | ABL1 (0.56) | ABL1OPRM1KCNH2 | |
| SCHEMBL28523803 | 0.90 | ABL1 (0.54) | ABL1 | |
| SCHEMBL22939415 | 0.85 | ABL1 (0.53) | ABL1 | |
| SCHEMBL30046925 | 0.85 | ABL1 (0.53) | ABL1 | |
| SCHEMBL22938707 | 0.84 | ABL1 (0.64) | ABL1KCNH2 | |
| SCHEMBL30046879 | 0.84 | ABL1 (0.64) | ABL1KCNH2 | |
| SCHEMBL22939418 | 0.83 | ABL1 (0.48) | ABL1 | |
| SCHEMBL30046805 | 0.83 | ABL1 (0.48) | ABL1 | |
| SCHEMBL23091734 | 0.82 | ABL1 (0.62) | ABL1OPRM1KCNH2 | |
| SCHEMBL29687314 | 0.82 | ABL1 (0.62) | ABL1OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112300129-B | Heterocyclic compounds as BCR-ABL inhibitors | 苏州亚盛药业有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-112300129-B | Heterocyclic compounds as BCR-ABL inhibitors | 苏州亚盛药业有限公司 | 2021-09-14 | — | — | CN | disclosed |
| WO-2021018194-A1 | HETEROCYCLIC COMPOUNDS AS BCR-ABL INHIBITORS | ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) | 2021-02-04 | — | — | WO | disclosed |
| CN-112300129-A | Heterocyclic compounds as BCR-ABL inhibitors | 苏州亚盛药业有限公司 | 2021-02-02 | — | — | CN | disclosed |